11th Annual Spring to Life
Conference on Genitourinary and Gynecologic Cancers
Thursday, May 2, 2024 - Friday, May 3, 2024
Albany Capital Center, Albany, NY
COMMUNITY-BASED CANCER CARE AFFILIATE:
Event Information
- The conference will be Live In-Person and Online via a Live Broadcast
Registration Fees:
Per day:
$0 Fellows/Students
$0 NYOH, Albany Med, and US Oncology
$25 APP
$35 MD
$200 Industry
Cancellation Policy:
Cancellations and refunds will be processed based on the following:
Up to 30 days prior to the conference = 100%
29 - 15 days prior to the conference = 50%
14-7 days prior to the conference = 25%
6-0 days prior to the conference = 0%
If you would like to request a refund, please email [email protected]
Registration
Conference Materials
SIGN IN SHEET - Sign in for each session you attend
PROGRAM GUIDEBOOK
AGENDA
PRODUCT THEATER
SUPPORT ACKNOWLEDGEMENT
EDUCATIONAL GOAL
TARGET AUDIENCE
LEARNING OBJECTIVES
After participating in this activity, learners will be better able to:
- Determine optimal surgical options for non-invasive and invasive urothelial cancers, renal cancers, and localized prostate cancer.
- Evaluate systemic therapy options, including new targeted therapies, for non-invasive and invasive urothelial cancers, renal cancers, prostate cancers, germ cell tumors, and testicular cancer.
- Understand current radiation therapy management of localized prostate cancer.
AGENDA
CONFERENCE COURSE CHAIR
Ira Zackon, MD
New York Oncology Hematology,
Immediate Past President
Hematologist/Medical Oncologist
NYOH Albany Medical Center
Clinical Assistant Professor
Albany Medical College
Albany, NY
SESSION CHAIR
David R. Shaffer, MD
Medical Oncologist NYOH, retired
President Board of Directors, NYOH Community Cancer Foundation
Albany, New York
FACULTY
Timothy Donahue, MD (MSKCC)
Darren Feldman, MD (MSKCC)
Ari Hakimi, MD (MSKCC)
Gopa Iyer, MD (MSKCC)
Justin Juliano, MD (NYOH)
Rahul Ravilla, MD (NYOH)
Susan Slovin, MD (MSKCC)
Karim Touijer, MD (MSKCC)
Martin Voss, MD (MSKCC)
EDUCATIONAL GOAL
TARGET AUDIENCE
LEARNING OBJECTIVES
After participating in this activity, learners will be better able to:
1. Determine the optimal integration of combined modality systemic, intraperitoneal and surgical debulking management of ovarian cancer
2. Understand the use of systemic immunotherapy, as well as individualized decisions on pelvic radiation therapy in advanced endometrial cancer
3. Update current screening and prevention in cervical, endometrial and ovarian cancers, including obesity management.
AGENDA
CONFERENCE COURSE CHAIR
Ira Zackon, MD
New York Oncology Hematology,
Immediate Past President
Hematologist/Medical Oncologist
NYOH Albany Medical Center
Clinical Assistant Professor
Albany Medical College
Albany, NY
SESSION CHAIR
Heidi Godoy, DO
Gynecologic Oncologist
New York Oncology Hematology
Albany, NY
FACULTY
Gary Altwerger, MD (Yale)
Susana Campos, MD (Dana Farber)
Olga Filippova, MD (Lenox Hill Hospital)
Melanie Hawver, MD (St. Peter's Health Partners)
James Izzano, MD (St. Mary's Hospital Amsterdam)
Justin Juliano, MD (NYOH)
Joshua Kesterson, MD (UPMC)
Thomas Krivak, MD (Allegheny Health Network)
Shashi Lele, MD (Roswell Park)
Colleen Murray, NP (NYOH)
Mary Paquet, NP (Elevate Health)
Rebecca Phaeton, MD (GSK)
Danielle Rooney, MD (Community Care Physicians)
Mark Shahin, MD (Alliance Health)
SUPPORT OPPORTUNITIES
Click HERE for the sponsorship opportunity details.
If you are interested in a Product Theater or Onsite Meeting Space, please email [email protected] to discuss availability before you complete the application.
To complete the application, please go to: https://cmersvp.com/exhibit-processing-form/
For custom sponsorship packages, please get in touch with Nicole @ 815-861-9069 / [email protected]
Exhibitor Information - Logistics - Click HERE
Exhibitor Name Badge Request – https://cmersvp.com/vendor-name-badges/
To view previous years' programs, collaborators, educational grant providers, sponsors and exhibitors, please view the Conference Archive tab.
CONFERENCE VENUE
Albany Capital Center
2nd Floor
55 Eagle Street
Albany, NY 12207
PARKING
In addition to the dedicated ACC Garage, the following garages are all directly connected to the ACC via enclosed walkways:
- MVP Arena (formerly Times Union Center) Parking Garage, located at 100 Beaver Street, Albany, NY 12207.
- Renaissance Albany Parking Garage, located at 49 Howard Street.
- Empire State Plaza Visitor Parking Lot located at S Mall Arterial, V Lot.
CONFERENCE HOTEL
Renaissance Albany Hotel
144 State Street
Albany, NY 12207
The discounted hotel rate is $209 plus applicable taxes and fees.
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and myMedEd, Inc. MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The Medical Society of the State of New York designates this live activity for a maximum of 12.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
As an ACCME-accredited provider, MSSNY will identify and mitigate relevant financial relationships of all individuals who control CME content.
ASSURANCE OF BALANCED, UNBIASED, AND FAIR CONTENT
As an ACCME-accredited provider, MSSNY must identify and mitigate relevant financial relationships of all individuals controlling CME content.
Financial relationships are relevant if the following three conditions are met for the prospective person who will control the content of the education:
- A financial relationship, in any amount, exists between the person in control of content and an ineligible company.
- The financial relationship existed during the past 24 months.
- The educational content is related to the products of an ineligible company with whom the person has a financial relationship.
Mechanisms to ensure that presentations are free from commercial bias are in place. Faculty will also disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.
Faculty and Planner Disclosures
The mission of Spring to Life™ is to reflect and transmit all that is evolving in the whole of the field of oncology. The annual conference continues to bring together faculty speakers that reflect local, regional and national expertise in the field. This collaboration of community-based oncologists with academic leaders highlights the impact of the research that advances our understanding and ultimately impacts the lives of our patients whom we serve.
Click on the links below to view the programs from years past.
- AbbVie, Inc.
- AbbVie Oncology
- Adaptive Biotechnologies
- ADC Therapeutics
- Agios
- Alexion Pharmaceuticals, Inc.
- Amgen (Oncology and Hematology)
- Amyloidosis Support Groups
- Apellis Pharmaceuticals
- Astellas Pharma US, Inc.
- AstraZeneca US
- Be The Match
- BeiGene
- Boehringer Ingelheim
- Blueprint Medicines
- Bristol-Myers Squibb
- Bristol-Myers Squibb Oncology
- Cancer Hope Network
- Caris Life Sciences
- Celgene Corporation
- CLL Support Group of Albany
- CRAAB
- CTI BioPharma
- Daiichi Sankyo, Inc.
- Eisai Oncology, Inc.
- Epizyme, Inc.
- Exelixis, Inc.
- Foundation Medicine
- Genentech USA, Inc.
- Genomic Health, Inc.
- Genoptix, A NeoGenomics Company
- Gilead Sciences, Inc.
- GlaxoSmithKline
- Global Blood Therapeutics, Inc.
- Guardant Health, Inc.
- Incyte Corporation
- Ipsen
- Janssen Biotech, Inc.
- Janssen Pharmaceuticals, Inc
- Jazz Pharmaceuticals plc
- Karyopharm Therapeutics
- Kite Pharma
- Kyowa Kirin
- Leukemia & Lymphoma Society
- Lilly USA, LLC
- Lung Cancer Research Foundation
- Maddie’s Mark
- Make-A-Wish Northeast New York
- Med News Online
- Melodies Center at the Children’s Hospital, Albany
- Medical Center
- Merck
- Millennium Pharmaceuticals, Inc.
- Morphosys US
- NeoGenomics Laboratories, Inc
- New York Oncology Hematology
- Nick’s Fight to be Healed Foundation
- Novartis
- Novartis Hematology
- Novartis Oncology Onyx Pharmaceuticals, Inc.
- Oncopeptides
- Otsuka America Pharmaceutical, Inc.
- Pfizer
- Pfizer Oncology
- Pharmacyclics LLC, an AbbVie Company
- Pharmacosmos Therapeutics
- Prometheus
- Rigel Pharmaceuticals
- Sandoz BioPharmaceuticals
- Sanofi-Genzyme & Regeneron
- Seagen
- Servier Pharmaceuticals
- Shire
- Spectrum Pharmaceuticals
- Stemline Therapeutics
- Susan G. Komen
- Taiho
- Takeda Hematology
- Takeda Oncology
- Teva Pharmaceutical Industries Ltd.
- TG Therapeutics
- Verastem, Inc.
The mission of Spring to Life™ is to reflect and transmit all that is evolving in the whole of the field of oncology. The annual conference continues to bring together faculty speakers that reflect local, regional and national expertise in the field. This collaboration of community-based oncologists with academic leaders highlights the impact of the research that advances our understanding and ultimately impacts the lives of our patients whom we serve.
Click on the links below to view the programs from years past.
Thank you to the collaborators, educational grant providers, sponsors and exhibitors, past and present, who have made this event possible:
- AbbVie, Inc.
- AbbVie Oncology
- Adaptive Biotechnologies
- ADC Therapeutics
- Agios
- Alexion Pharmaceuticals, Inc.
- Amgen (Oncology and Hematology)
- Amyloidosis Support Groups
- Apellis Pharmaceuticals
- Astellas Pharma US, Inc.
- AstraZeneca US
- Be The Match
- BeiGene
- Boehringer Ingelheim
- Blueprint Medicines
- Bristol-Myers Squibb
- Bristol-Myers Squibb Oncology
- Cancer Hope Network
- Caris Life Sciences
- Celgene Corporation
- CLL Support Group of Albany
- CRAAB
- CTI BioPharma
- Daiichi Sankyo, Inc.
- Eisai Oncology, Inc.
- Epizyme, Inc.
- Exelixis, Inc.
- Foundation Medicine
- Genentech USA, Inc.
- Genomic Health, Inc.
- Genoptix, A NeoGenomics Company
- Gilead Sciences, Inc.
- GlaxoSmithKline
- Global Blood Therapeutics, Inc.
- Guardant Health, Inc.
- Incyte Corporation
- Ipsen
- Janssen Biotech, Inc.
- Janssen Pharmaceuticals, Inc
- Jazz Pharmaceuticals plc
- Karyopharm Therapeutics
- Kite Pharma
- Kyowa Kirin
- Leukemia & Lymphoma Society
- Lilly USA, LLC
- Lung Cancer Research Foundation
- Maddie’s Mark
- Make-A-Wish Northeast New York
- Med News Online
- Melodies Center at the Children’s Hospital, Albany
- Medical Center
- Merck
- Millennium Pharmaceuticals, Inc.
- Morphosys US
- NeoGenomics Laboratories, Inc
- New York Oncology Hematology
- Nick’s Fight to be Healed Foundation
- Novartis
- Novartis Hematology
- Novartis Oncology Onyx Pharmaceuticals, Inc.
- Oncopeptides
- Otsuka America Pharmaceutical, Inc.
- Pfizer
- Pfizer Oncology
- Pharmacyclics LLC, an AbbVie Company
- Pharmacosmos Therapeutics
- Prometheus
- Rigel Pharmaceuticals
- Sandoz BioPharmaceuticals
- Sanofi-Genzyme & Regeneron
- Seagen
- Servier Pharmaceuticals
- Shire
- Spectrum Pharmaceuticals
- Stemline Therapeutics
- Susan G. Komen
- Taiho
- Takeda Hematology
- Takeda Oncology
- Teva Pharmaceutical Industries Ltd.
- TG Therapeutics
- Verastem, Inc.
PROGRAM OVERVIEW
TARGET AUDIENCE
LEARNING OBJECTIVES
After participating in this activity, learners will be better able to:
- Understand the current classification system of the lymphoma
- Discuss updated data on novel agents and therapeutic approaches for patients with aggressive lymphoma.
- Discuss current standard of care approach in patient with newly diagnosed and relapsed refractory aggressive B cell lymphoma and T cell lymphoma.
- Understand the diagnostic and management approaches in patient with uncommon presentation of lymphoma and CNS lymphoma.
- Understand the disease process and treatment strategies in patients with Hodgkin Lymphoma.
- Identify the unmet need and upcoming strategies in elderly patients with lymphoma.
- Understand the complex diagnosis paradigm and management of thrombotic microangiopathies
Host
ACCREDITATION Statement
Credit Designation Statement
The Medical Society of the State of New York designates this live activity for a maximum of 8.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ASSURANCE AOF BALANCED, UNBIASED, AND FAIR CONTENT: As an ACCME-accredited provider, MSSNY must identify and mitigate relevant financial relationships of all individuals controlling CME content.
Financial relationships are relevant if the following three conditions are met for the prospective person who will control the content of the education:
- A financial relationship, in any amount, exists between the person in control of content and an ineligible company.
- The financial relationship existed during the past 24 months
- The educational content is related to the products of an ineligible company with whom the person has a financial relationship.
Mechanisms to ensure that presentations are free from commercial bias are in place. Faculty will also disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.
PLANNING COMMITTEE and Co-Chairs/Moderators
Ira Zackon, MD
New York Oncology Hematology,
Immediate Past President
Hematologist/Medical Oncologist
NYOH Albany Medical Center
Clinical Assistant Professor
Albany Medical College
Albany, NY
Mihir Raval, MD, MPH
Hematology and Stem cell transplant
New York Oncology and Hematology,
Clinical Assistant Professor
Transfusion Committee Chair
Albany Medical College
Albany, NY/p>
Faculty
Mahmoud Aldyab, MD
Pathology Residency
Albany Medical Center
Albany, NY
Jennifer Crombie, MD
Assistant Professor of Medicine
Dana-Farber Cancer Institute
Boston, MA
Reju George, MD
Hematologist-Oncologist
New York Oncology Hematology
Albany, NY
Steven Horwitz, MD
Medical Oncologist
Member and Attending Physician
Memorial Sloan Kettering Cancer Center
New York, NY
Austin Kim, MD
Instructor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Boston, MA
Jeffrey Laurence, MD
Professor of Medicine
Weill Cornell Medicine
New York, NY
Kah Poh (Melissa) Loh, MBBCh BAO, MS
Assistant Professor
University of Rochester Medical Center
Rochester, NY
Reid W. Merryman, MD
Assistant Professor
Dana-Farber Cancer Institute
Boston, MA
Alison Moskowitz, MD
Associate Attending
Memorial Sloan Kettering Cancer Center
New York, NY
Tipu Nazeer, MD
Professor and Program Director
Director, Hematopathology
Albany Medical Center
Albany, NY
Patrick Reagan, MD
Associate Professor
Wilmot Cancer Institute
Rochester, NY
Susan Weaver, MD
Assistant Professor
Albany Medical Center
New York Oncology Hematology
Albany, NY
Qin Zen, MD, PhD
Attending Physician
New York Oncology Hematology
Albany, NY
Faculty Documentation
Thank you for agreeing to participate in the conference!
Please click on the link below to submit your faculty documentation.
Email Nicole Falco if you have any questions: [email protected]
Faculty
Ghassan Abou-Alfa, MD, MBA
Professor
Memorial Sloan Kettering Cancer Center
New York, NY
Lindy Davis, MD, FACS
Assistant Professor of Surgery
Albany Medical Center
Albany, NY
David H. Ilson, MD PhD
Attending Physician
Gastrointestinal Oncology Service
Division of Solid Tumor Oncology
Department of Medicine
Memorial Sloan Kettering Cancer Center
Professor of Medicine
Weill Cornell Medical College
New York, NY
Rebecca Keim, MD, FACS
Hepato-Pancreatic-Biliary Surgeon
St. Peter's Health Partners Medical Associates
Albany, NY
Jeffrey Meyerhardt, MD, MPH, FASCO
Chief Clinical Research Officer
Professor of Medicine
Dana-Farber Cancer Institute
Boston, MA
Eileen M. O’Reilly, MD
Winthrop Rockefeller Endowed Chair in Medical Oncology
Section Head, Hepatopancreaticobiliary & Neuroendocrine Cancers
Co-Director Medical Initiatives, David M. Rubenstein Center for Pancreatic Cancer
Chair, Institutional Review Board
Attending Physician, Member, Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College
New York, NY
Mitchell C. Posner M.D., FACS
Thomas D. Jones Professor of Surgery and Vice-Chairman
Chief, Section of General Surgery
and Surgical Oncology
Physician-in-Chief, UCM Comprehensive Cancer Center
Professor, Radiation and Cellular Oncology
University of Chicago Medicine
Chicago, IL
Benjamin L. Schlechter, MD
Instructor
Harvard Medical School
Attending Physician
Gastrointestinal Cancer Center
Dana Farber Cancer Institute
Boston, MA
Christopher Stark, MD
Assistant Professor of Radiology
Vascular and Interventional Radiology
Albany Medical College
Jonathan Strosberg, MD
Professor
Moffitt Cancer Center
Tampa, FL
Conference Organizers Contact Information:
1-800-973-0665
[email protected]
To view previous years' programs, collaborators, educational grant providers, sponsors and exhibitors, please click here.
Hotel
Attendees of the Spring to Life Conference are welcome to book a room at the conference hotel for the negotiated rate of $199 per night plus tax.
To book a room, click here:
This Activity Is Planned By myMedEd, Inc.
Accredited Provider